Pet Anthelmintic Drugs Market 2027 By Target Pathogen, Distribution Channel | The Insight Partners

Pet Anthelmintic Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Target Pathogen (Ascaris Lumbricoides [Roundworm], Trichuris Trichiura [Whipworm], Enterobius Vermicularis [Pinworm], Ancylostoma Duodenale [Hookworm], Others); Distribution Channel (Veterinary Pharmacies, Veterinary Hospitals and Clinics)

Report Code: TIPRE00013986 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Anthelmintics are drugs that are used to treat infections with parasitic worms. This includes both flat worms, e.g., flukes and tapeworms and round worms, i.e., nematodes. They are of huge importance for veterinary medicine.

MARKET DYNAMICS

The pet anthelmintic drugs market is driving due to the increasing prevalence of rise in prevalence of helminth infections caused by roundworm, hookworm, whipworm, and others worms. However, rise in drug resistance to most commonly prescribed anthelmintic drugs may impede the market growth in the review period.

MARKET SCOPE

The "Pet Anthelmintic Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of pet anthelmintic drugs market with detailed market segmentation by target pathogen, and distribution channel. The pet anthelmintic drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in pet anthelmintic drugs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The pet anthelmintic drugs market is segmented on the basis of target pathogen, and distribution channel. On the basis of target pathogen, the market is categorized as ascaris lumbricoides [roundworm], trichuris trichiura [whipworm], enterobius vermicularis [pinworm], ancylostoma duodenale [hookworm], and others. On the basis of distribution channel, the market is categorized as veterinary pharmacies, and veterinary hospitals and clinics.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the pet anthelmintic drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pet anthelmintic drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting pet anthelmintic drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the pet anthelmintic drugs market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the pet anthelmintic drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from pet anthelmintic drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for pet anthelmintic drugs in the global market. Below mentioned is the list of few companies engaged in the pet anthelmintic drugs market.

The report also includes the profiles of key players in pet anthelmintic drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Novartis AG
  •  Cipla Inc.
  •  Sun Pharmaceutical Industries Ltd
  •  Amneal Pharmaceuticals LLC. (Impax Laboratories, Inc.)
  •  Zoetis, Inc.
  •  GlaxoSmithKline plc
  •  Bayer AG
  •  Merck & Co., Inc. (Intervet Inc.)
  •  Boehringer Ingelheim International GmbH
  •  Virbac

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pet Anthelmintic Drugs Market - By Target Pathogen
1.3.2 Pet Anthelmintic Drugs Market - By Distribution Channel
1.3.3 Pet Anthelmintic Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PET ANTHELMINTIC DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PET ANTHELMINTIC DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PET ANTHELMINTIC DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. PET ANTHELMINTIC DRUGS - GLOBAL MARKET OVERVIEW
6.2. PET ANTHELMINTIC DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PET ANTHELMINTIC DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - TARGET PATHOGEN
7.1. OVERVIEW
7.2. TARGET PATHOGEN MARKET FORECASTS AND ANALYSIS
7.3. ASCARIS LUMBRICOIDES [ROUNDWORM]
7.3.1. Overview
7.3.2. Ascaris Lumbricoides [Roundworm] Market Forecast and Analysis
7.4. TRICHURIS TRICHIURA [WHIPWORM]
7.4.1. Overview
7.4.2. Trichuris Trichiura [Whipworm] Market Forecast and Analysis
7.5. ENTEROBIUS VERMICULARIS [PINWORM]
7.5.1. Overview
7.5.2. Enterobius Vermicularis [Pinworm] Market Forecast and Analysis
7.6. ANCYLOSTOMA DUODENALE [HOOKWORM]
7.6.1. Overview
7.6.2. Ancylostoma Duodenale [Hookworm] Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. PET ANTHELMINTIC DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. VETERINARY PHARMACIES
8.3.1. Overview
8.3.2. Veterinary Pharmacies Market Forecast and Analysis
8.4. VETERINARY HOSPITALS AND CLINICS
8.4.1. Overview
8.4.2. Veterinary Hospitals and Clinics Market Forecast and Analysis
9. PET ANTHELMINTIC DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Pet Anthelmintic Drugs Market Overview
9.1.2 North America Pet Anthelmintic Drugs Market Forecasts and Analysis
9.1.3 North America Pet Anthelmintic Drugs Market Forecasts and Analysis - By Target Pathogen
9.1.4 North America Pet Anthelmintic Drugs Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Pet Anthelmintic Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Pet Anthelmintic Drugs Market
9.1.5.1.1 United States Pet Anthelmintic Drugs Market by Target Pathogen
9.1.5.1.2 United States Pet Anthelmintic Drugs Market by Distribution Channel
9.1.5.2 Canada Pet Anthelmintic Drugs Market
9.1.5.2.1 Canada Pet Anthelmintic Drugs Market by Target Pathogen
9.1.5.2.2 Canada Pet Anthelmintic Drugs Market by Distribution Channel
9.1.5.3 Mexico Pet Anthelmintic Drugs Market
9.1.5.3.1 Mexico Pet Anthelmintic Drugs Market by Target Pathogen
9.1.5.3.2 Mexico Pet Anthelmintic Drugs Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Pet Anthelmintic Drugs Market Overview
9.2.2 Europe Pet Anthelmintic Drugs Market Forecasts and Analysis
9.2.3 Europe Pet Anthelmintic Drugs Market Forecasts and Analysis - By Target Pathogen
9.2.4 Europe Pet Anthelmintic Drugs Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Pet Anthelmintic Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Pet Anthelmintic Drugs Market
9.2.5.1.1 Germany Pet Anthelmintic Drugs Market by Target Pathogen
9.2.5.1.2 Germany Pet Anthelmintic Drugs Market by Distribution Channel
9.2.5.2 France Pet Anthelmintic Drugs Market
9.2.5.2.1 France Pet Anthelmintic Drugs Market by Target Pathogen
9.2.5.2.2 France Pet Anthelmintic Drugs Market by Distribution Channel
9.2.5.3 Italy Pet Anthelmintic Drugs Market
9.2.5.3.1 Italy Pet Anthelmintic Drugs Market by Target Pathogen
9.2.5.3.2 Italy Pet Anthelmintic Drugs Market by Distribution Channel
9.2.5.4 Spain Pet Anthelmintic Drugs Market
9.2.5.4.1 Spain Pet Anthelmintic Drugs Market by Target Pathogen
9.2.5.4.2 Spain Pet Anthelmintic Drugs Market by Distribution Channel
9.2.5.5 United Kingdom Pet Anthelmintic Drugs Market
9.2.5.5.1 United Kingdom Pet Anthelmintic Drugs Market by Target Pathogen
9.2.5.5.2 United Kingdom Pet Anthelmintic Drugs Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Pet Anthelmintic Drugs Market Overview
9.3.2 Asia-Pacific Pet Anthelmintic Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Pet Anthelmintic Drugs Market Forecasts and Analysis - By Target Pathogen
9.3.4 Asia-Pacific Pet Anthelmintic Drugs Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Pet Anthelmintic Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Pet Anthelmintic Drugs Market
9.3.5.1.1 Australia Pet Anthelmintic Drugs Market by Target Pathogen
9.3.5.1.2 Australia Pet Anthelmintic Drugs Market by Distribution Channel
9.3.5.2 China Pet Anthelmintic Drugs Market
9.3.5.2.1 China Pet Anthelmintic Drugs Market by Target Pathogen
9.3.5.2.2 China Pet Anthelmintic Drugs Market by Distribution Channel
9.3.5.3 India Pet Anthelmintic Drugs Market
9.3.5.3.1 India Pet Anthelmintic Drugs Market by Target Pathogen
9.3.5.3.2 India Pet Anthelmintic Drugs Market by Distribution Channel
9.3.5.4 Japan Pet Anthelmintic Drugs Market
9.3.5.4.1 Japan Pet Anthelmintic Drugs Market by Target Pathogen
9.3.5.4.2 Japan Pet Anthelmintic Drugs Market by Distribution Channel
9.3.5.5 South Korea Pet Anthelmintic Drugs Market
9.3.5.5.1 South Korea Pet Anthelmintic Drugs Market by Target Pathogen
9.3.5.5.2 South Korea Pet Anthelmintic Drugs Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Pet Anthelmintic Drugs Market Overview
9.4.2 Middle East and Africa Pet Anthelmintic Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Pet Anthelmintic Drugs Market Forecasts and Analysis - By Target Pathogen
9.4.4 Middle East and Africa Pet Anthelmintic Drugs Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Pet Anthelmintic Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Pet Anthelmintic Drugs Market
9.4.5.1.1 South Africa Pet Anthelmintic Drugs Market by Target Pathogen
9.4.5.1.2 South Africa Pet Anthelmintic Drugs Market by Distribution Channel
9.4.5.2 Saudi Arabia Pet Anthelmintic Drugs Market
9.4.5.2.1 Saudi Arabia Pet Anthelmintic Drugs Market by Target Pathogen
9.4.5.2.2 Saudi Arabia Pet Anthelmintic Drugs Market by Distribution Channel
9.4.5.3 U.A.E Pet Anthelmintic Drugs Market
9.4.5.3.1 U.A.E Pet Anthelmintic Drugs Market by Target Pathogen
9.4.5.3.2 U.A.E Pet Anthelmintic Drugs Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Pet Anthelmintic Drugs Market Overview
9.5.2 South and Central America Pet Anthelmintic Drugs Market Forecasts and Analysis
9.5.3 South and Central America Pet Anthelmintic Drugs Market Forecasts and Analysis - By Target Pathogen
9.5.4 South and Central America Pet Anthelmintic Drugs Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Pet Anthelmintic Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Pet Anthelmintic Drugs Market
9.5.5.1.1 Brazil Pet Anthelmintic Drugs Market by Target Pathogen
9.5.5.1.2 Brazil Pet Anthelmintic Drugs Market by Distribution Channel
9.5.5.2 Argentina Pet Anthelmintic Drugs Market
9.5.5.2.1 Argentina Pet Anthelmintic Drugs Market by Target Pathogen
9.5.5.2.2 Argentina Pet Anthelmintic Drugs Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PET ANTHELMINTIC DRUGS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. PET ANTHELMINTIC DRUGS MARKET, KEY COMPANY PROFILES
12.1. NOVARTIS AG
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. CIPLA INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SUN PHARMACEUTICAL INDUSTRIES LTD
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. AMNEAL PHARMACEUTICALS LLC. (IMPAX LABORATORIES, INC.)
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ZOETIS, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. GLAXOSMITHKLINE PLC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BAYER AG
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MERCK AND CO., INC. (INTERVET INC.)
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. VIRBAC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
12.11.
12.11.1. Key Facts
12.11.2. Business Description
12.11.3. Products and Services
12.11.4. Financial Overview
12.11.5. SWOT Analysis
12.11.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Novartis AG
2. Cipla Inc.
3. Sun Pharmaceutical Industries Ltd
4. Amneal Pharmaceuticals LLC. (Impax Laboratories, Inc.)
5. Zoetis, Inc.
6. GlaxoSmithKline plc
7. Bayer AG
8. Merck & Co., Inc. (Intervet Inc.)
9. Boehringer Ingelheim International GmbH
10. Virbac

TIPRE00013986
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking